HEADER HYDROLASE/HYDROLASE INHIBITOR 09-DEC-10 3PWW TITLE ENDOTHIAPEPSIN IN COMPLEX WITH SAQUINAVIR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTATE PROTEASE; COMPND 5 EC: 3.4.23.22 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPHONECTRIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116 KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.KOESTER,A.HEINE,G.KLEBE REVDAT 4 30-OCT-24 3PWW 1 REMARK REVDAT 3 13-SEP-23 3PWW 1 COMPND REMARK HETNAM HETSYN REVDAT 2 08-FEB-12 3PWW 1 JRNL REVDAT 1 14-DEC-11 3PWW 0 JRNL AUTH J.BEHNEN,H.KOSTER,G.NEUDERT,T.CRAAN,A.HEINE,G.KLEBE JRNL TITL EXPERIMENTAL AND COMPUTATIONAL ACTIVE SITE MAPPING AS A JRNL TITL 2 STARTING POINT TO FRAGMENT-BASED LEAD DISCOVERY. JRNL REF CHEMMEDCHEM V. 7 248 2012 JRNL REFN ISSN 1860-7179 JRNL PMID 22213702 JRNL DOI 10.1002/CMDC.201100490 REMARK 2 REMARK 2 RESOLUTION. 1.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.77 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 90280 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.163 REMARK 3 R VALUE (WORKING SET) : 0.162 REMARK 3 FREE R VALUE : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1859 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.7810 - 2.6277 0.95 9147 195 0.1661 0.1787 REMARK 3 2 2.6277 - 2.0859 1.00 9448 200 0.1622 0.1912 REMARK 3 3 2.0859 - 1.8223 0.99 9319 198 0.1517 0.1552 REMARK 3 4 1.8223 - 1.6557 0.98 9260 198 0.1480 0.1743 REMARK 3 5 1.6557 - 1.5371 0.97 9145 194 0.1463 0.1497 REMARK 3 6 1.5371 - 1.4464 0.95 8989 186 0.1490 0.1591 REMARK 3 7 1.4464 - 1.3740 0.93 8775 181 0.1592 0.1817 REMARK 3 8 1.3740 - 1.3142 0.90 8527 188 0.1772 0.1942 REMARK 3 9 1.3142 - 1.2636 0.89 8276 164 0.1951 0.2078 REMARK 3 10 1.2636 - 1.2200 0.79 7535 155 0.2157 0.2409 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.45 REMARK 3 B_SOL : 57.78 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.920 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.89460 REMARK 3 B22 (A**2) : 0.50870 REMARK 3 B33 (A**2) : 0.38590 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.91450 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2512 REMARK 3 ANGLE : 1.135 3455 REMARK 3 CHIRALITY : 0.070 413 REMARK 3 PLANARITY : 0.005 437 REMARK 3 DIHEDRAL : 13.137 854 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3PWW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1000062911. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR KMC REMARK 200 -2 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 94163 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.220 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.22 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.33200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1OEW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NH4AC, 0.1M ACETATE-BUFFER PH REMARK 280 4.6, 26% PEG4000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.51950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 111 CG CD CE NZ REMARK 470 LYS A 142 CG CD CE NZ REMARK 470 LYS A 149 CG CD CE NZ REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 LYS A 243 CG CD CE NZ REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: (2S)-N-[(2S,3R)-4-[(2S,3S,4AS,8AS)-3-(TERT- REMARK 630 BUTYLCARBAMOYL)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-1H-ISOQUINOLIN-2-YL]-3- REMARK 630 HYDROXY-1 -PHENYL-BUTAN-2-YL]-2-(QUINOLIN-2-YLCARBONYLAMINO) REMARK 630 BUTANEDIAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 ROC A 1001 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: QNC ASN HP0 NTB REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROC A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 3002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PRS RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN IN COMPLEX WITH RITONAVIR DBREF 3PWW A 1 330 UNP P11838 CARP_CRYPA 90 419 SEQRES 1 A 330 SER THR GLY SER ALA THR THR THR PRO ILE ASP SER LEU SEQRES 2 A 330 ASP ASP ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO SEQRES 3 A 330 ALA GLN THR LEU ASN LEU ASP PHE ASP THR GLY SER SER SEQRES 4 A 330 ASP LEU TRP VAL PHE SER SER GLU THR THR ALA SER GLU SEQRES 5 A 330 VAL ASP GLY GLN THR ILE TYR THR PRO SER LYS SER THR SEQRES 6 A 330 THR ALA LYS LEU LEU SER GLY ALA THR TRP SER ILE SER SEQRES 7 A 330 TYR GLY ASP GLY SER SER SER SER GLY ASP VAL TYR THR SEQRES 8 A 330 ASP THR VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN SEQRES 9 A 330 ALA VAL GLU SER ALA LYS LYS VAL SER SER SER PHE THR SEQRES 10 A 330 GLU ASP SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SEQRES 11 A 330 SER THR LEU ASN THR VAL SER PRO THR GLN GLN LYS THR SEQRES 12 A 330 PHE PHE ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL SEQRES 13 A 330 PHE THR ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR SEQRES 14 A 330 ASN PHE GLY PHE ILE ASP THR THR ALA TYR THR GLY SER SEQRES 15 A 330 ILE THR TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP SEQRES 16 A 330 GLU TRP THR SER THR GLY TYR ALA VAL GLY SER GLY THR SEQRES 17 A 330 PHE LYS SER THR SER ILE ASP GLY ILE ALA ASP THR GLY SEQRES 18 A 330 THR THR LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA SEQRES 19 A 330 TYR TRP ALA GLN VAL SER GLY ALA LYS SER SER SER SER SEQRES 20 A 330 VAL GLY GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SEQRES 21 A 330 SER PHE THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE SEQRES 22 A 330 PRO GLY ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SEQRES 23 A 330 SER SER SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY SEQRES 24 A 330 ILE GLY ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA SEQRES 25 A 330 ALA PHE VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU SEQRES 26 A 330 GLY PHE ALA SER LYS HET ROC A1001 49 HET GOL A3002 6 HETNAM ROC (2S)-N-[(2S,3R)-4-[(2S,3S,4AS,8AS)-3-(TERT- HETNAM 2 ROC BUTYLCARBAMOYL)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-1H- HETNAM 3 ROC ISOQUINOLIN-2-YL]-3-HYDROXY-1 -PHENYL-BUTAN-2-YL]-2- HETNAM 4 ROC (QUINOLIN-2-YLCARBONYLAMINO)BUTANEDIAMIDE HETNAM GOL GLYCEROL HETSYN ROC FORTOVASE; SAQUINAVIR; RO 31-8959 HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ROC C38 H50 N6 O5 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *447(H2 O) HELIX 1 1 THR A 49 VAL A 53 5 5 HELIX 2 2 THR A 60 SER A 64 5 5 HELIX 3 3 SER A 113 GLU A 118 1 6 HELIX 4 4 PHE A 130 ASN A 134 5 5 HELIX 5 5 THR A 143 LYS A 149 1 7 HELIX 6 6 ALA A 150 LEU A 152 5 3 HELIX 7 7 PRO A 228 ALA A 237 1 10 HELIX 8 8 PRO A 274 TYR A 277 5 4 HELIX 9 9 GLY A 306 LYS A 311 1 6 SHEET 1 A 9 LYS A 68 SER A 78 0 SHEET 2 A 9 SER A 84 VAL A 96 -1 O VAL A 89 N LEU A 70 SHEET 3 A 9 TYR A 17 ILE A 23 -1 N GLN A 22 O SER A 95 SHEET 4 A 9 GLY A 3 PRO A 9 -1 N THR A 8 O ILE A 18 SHEET 5 A 9 GLY A 167 PHE A 171 -1 O PHE A 171 N GLY A 3 SHEET 6 A 9 VAL A 156 ASP A 160 -1 N THR A 158 O ASN A 170 SHEET 7 A 9 PHE A 314 ASN A 318 -1 O PHE A 317 N PHE A 157 SHEET 8 A 9 THR A 324 ALA A 328 -1 O GLY A 326 N VAL A 316 SHEET 9 A 9 THR A 184 ALA A 187 -1 N THR A 184 O PHE A 327 SHEET 1 B13 LYS A 68 SER A 78 0 SHEET 2 B13 SER A 84 VAL A 96 -1 O VAL A 89 N LEU A 70 SHEET 3 B13 LEU A 99 VAL A 112 -1 O VAL A 106 N TYR A 90 SHEET 4 B13 LEU A 41 VAL A 43 1 N LEU A 41 O GLU A 107 SHEET 5 B13 GLY A 124 GLY A 127 -1 O LEU A 125 N TRP A 42 SHEET 6 B13 GLN A 28 ASP A 35 1 N ASP A 35 O LEU A 126 SHEET 7 B13 TYR A 17 ILE A 23 -1 N THR A 19 O LEU A 32 SHEET 8 B13 GLY A 3 PRO A 9 -1 N THR A 8 O ILE A 18 SHEET 9 B13 GLY A 167 PHE A 171 -1 O PHE A 171 N GLY A 3 SHEET 10 B13 VAL A 156 ASP A 160 -1 N THR A 158 O ASN A 170 SHEET 11 B13 PHE A 314 ASN A 318 -1 O PHE A 317 N PHE A 157 SHEET 12 B13 THR A 324 ALA A 328 -1 O GLY A 326 N VAL A 316 SHEET 13 B13 THR A 184 ALA A 187 -1 N THR A 184 O PHE A 327 SHEET 1 C 7 ALA A 269 ILE A 273 0 SHEET 2 C 7 PHE A 262 VAL A 266 -1 N PHE A 262 O ILE A 273 SHEET 3 C 7 GLU A 196 VAL A 204 -1 N ALA A 203 O THR A 263 SHEET 4 C 7 LYS A 210 ALA A 218 -1 O LYS A 210 N TYR A 202 SHEET 5 C 7 ASN A 303 PHE A 305 1 O PHE A 305 N ILE A 217 SHEET 6 C 7 LEU A 225 LEU A 227 -1 N TYR A 226 O ILE A 304 SHEET 7 C 7 ILE A 294 SER A 296 1 O GLN A 295 N LEU A 225 SHEET 1 D 4 LYS A 243 SER A 245 0 SHEET 2 D 4 GLY A 250 PRO A 254 -1 O GLY A 250 N SER A 245 SHEET 3 D 4 SER A 289 GLY A 292 -1 O CYS A 290 N PHE A 253 SHEET 4 D 4 ASP A 279 PRO A 282 -1 N GLY A 281 O PHE A 291 SSBOND 1 CYS A 255 CYS A 290 1555 1555 2.04 CISPEP 1 THR A 25 PRO A 26 0 -7.31 CISPEP 2 SER A 137 PRO A 138 0 6.07 SITE 1 AC1 22 ASP A 15 ASP A 33 ASP A 35 GLY A 37 SITE 2 AC1 22 SER A 78 TYR A 79 GLY A 80 ASP A 81 SITE 3 AC1 22 PHE A 116 PHE A 194 ILE A 217 ASP A 219 SITE 4 AC1 22 GLY A 221 THR A 222 THR A 223 TYR A 226 SITE 5 AC1 22 ILE A 304 HOH A 392 HOH A 503 HOH A 551 SITE 6 AC1 22 HOH A 641 HOH A 721 SITE 1 AC2 9 VAL A 272 PRO A 274 TYR A 277 ALA A 312 SITE 2 AC2 9 SER A 329 LYS A 330 HOH A 379 HOH A 445 SITE 3 AC2 9 HOH A 598 CRYST1 45.436 73.039 52.920 90.00 109.71 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022009 0.000000 0.007885 0.00000 SCALE2 0.000000 0.013691 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020072 0.00000